Autologous cancer therapies: How can we handle the complexity of the supply chain? (2018)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Other